ISSUE:: After 10 years of EUnetHTA collaborative project work and the launch of impact assessment process in 2016 by the European Commission, it is a perfect time to identify pragmatic solutions not only for making the European cooperation on HTA permanent after 2020 but also to support implementation of joint work at national level. The results of the impact assessment process and formal decision are expected by the end of 2017, thus making ISPOR’s Glasgow conference an ideal opportunity to review progress and understand stakeholder groups’ positions, challenges and opportunities for successfully working together towards a common goal in 2020 and beyond. What still needs to be done by 2020 to support a sustainable EU cooperation on HTA and ensure adequate uptake of joint HTA work at national level? What needs to be changed in how stakeholders work within and across each other? And what are the most important lessons from EUnetHTA for the next stage of the EU cooperation on HTA? OVERVIEW:: Any way forward should be informed both by the needs of the parties participating in the cooperation and by previous experiences in the national and EUnetHTA HTA processes, taking into account the policy processes within and across European countries. Concrete experiences and suggestions on how to improve the processes of joint work on HTA and how to implement the results of this work in national contexts would be the focus of the panel discussion. The panel will also address the opportunities and challenges of implementation for preferred policy option(s) initially outlined by the European Commission – each panelist will present the view of the constituency they represent: EUnetHTA/national HTA agencies, patients and industry. Issue Panel is organized in cooperation with EUnetHTA (European network for HTA).